Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




TF-Test Modified as New Diagnostic Tool for Human Enteroparasitosis

By LabMedica International staff writers
Posted on 01 Jul 2015
Intestinal parasitosis is highly prevalent worldwide, being among the main causes of illness and death in humans and currently, laboratory diagnosis of the intestinal parasites is accomplished through manual technical procedures, mostly developed decades ago, which justifies the development of more sensitive and practical techniques. More...


The three fecal tests (TF-Test) conventional parasitological technique has been providing effective and practical enteroparasitosis diagnosis for clinical analysis laboratories, especially by collecting three separate stool samples on alternate days and processing them at once with the laboratory procedure of parasite concentration and elimination of fecal debris by the principle of centrifugal sedimentation.

Scientists at the University of Campinas (São Paulo, Brazil) collected a total of 457 stool samples which were obtained from two sources in enteroparasitosis endemic areas. One source was from 185 children aged between 9 months and 7 years, who were enrolled in two municipal elementary schools located in the southwestern region of Campinas. The other source was from 272 individuals aged between four and 72 years, who attended public basic health units located in the south and southeastern regions in the municipality of Campinas. Samples were collected in TF-Test collector tubes for subsequent laboratory processing.

The new parasitological technique referred to as TF-Test Modified, was compared to three conventional parasitological techniques: TF-Test Conventional; Rugai, Mattos & Brisola; and Helm Test/Kato-Katz. Among the stool samples of 457 volunteers, 1,828 tests were performed by the four parasitological techniques resulting in detection of 14 species, from which six were related to protozoa and eight related to intestinal helminths. The sum of positive cases of all four techniques was 308 parasitic structures, including cysts, eggs, and larvae. Among them, 303 were identified by TF-Test Modified, 256 by TF-Test Conventional, 23 by Helm Test, and 19 by Rugai, Mattos & Brisola technique.TF-Test Modified allowed the preparation of temporary smears stained with Lugol's iodine solution, with a high concentration of parasite species, and largely free of fecal debris and leading to the diagnosis of Blastocystis hominis and other protozoa, by giving a sharper image.

The authors concluded that the modifications added to this new diagnostic technique provided high diagnostic values, increasing the sensitivity by 15.26% when compared to the second-best technique, TF-Test Conventional. The present study demonstrated that the TF-Test Modified technique can be comprehensively used in qualitative diagnosis of humans’ intestinal helminths and protozoa. The gain in diagnostic sensitivity provided by this new technique should have a laudable contribution to the laboratorial diagnosis, population surveys, and intestinal parasites control. The study was first published online on May 15, 2015, in the Journal of Clinical Laboratory Analysis.

Related Links:

University of Campinas  



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.